# Observational Registry on Patients With Endogenous CS to Document Safety and Effectiveness of Ketoconazole.

> **NCT04872920** · — · UNKNOWN · sponsor: **HRA Pharma** · enrollment: 200 (estimated)

## Conditions studied

- Cushing Syndrome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04872920
- **Lead sponsor:** HRA Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12-20
- **Primary completion:** 2023-03-01
- **Final completion:** 2024-03-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2022-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04872920

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04872920, "Observational Registry on Patients With Endogenous CS to Document Safety and Effectiveness of Ketoconazole.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04872920. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*